Experiment 447230
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IP |
| Organism | Empty organism |
| Citation | RUNOWICZ,CD: WIERNIK,PH: EINZIG,A: GOLDBERG,GL: HORWITZ,SB:. (1993). TAXOL IN OVARIAN CANCER.. 71(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | THIS REVIEW ARTICLE DISCUSSES PHASE I AND PHASE II STUDIES INVOLVING TAXOL. MAJOR POINTS DISCUSSED ARE DOSE LIMITING TOXICITIES, ADVANTAGES OF INTRAPERITONEAL ADMINISTRATION AND DOCUMENTED RESPONSE RATES OF 20-35%. |
| Dose amount | VAR |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |